Core Insights - Outset Medical, Inc. is anticipated to report a year-over-year increase in earnings despite lower revenues for the quarter ending December 2024, with a consensus outlook indicating a quarterly loss of $0.43 per share, reflecting a 27.1% increase from the previous year [1][3] - Revenues are projected to be $27.79 million, which is an 8.9% decline compared to the same quarter last year [3] Earnings Expectations - The upcoming earnings report is scheduled for February 19, and the stock may experience upward movement if the reported figures exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Outset Medical is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.18%, suggesting a bearish outlook from analysts [10] - Despite the negative Earnings ESP, the stock holds a Zacks Rank of 2, complicating predictions regarding an earnings beat [11] Historical Performance - In the last reported quarter, Outset Medical was expected to post a loss of $0.42 per share but achieved a loss of $0.39, resulting in a positive surprise of 7.14% [12] - Over the past four quarters, the company has surpassed consensus EPS estimates twice [13] Conclusion - Outset Medical does not currently appear to be a strong candidate for an earnings beat, and investors should consider additional factors when evaluating the stock ahead of the earnings release [16]
Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release